J. Blanc , N. Martinez Chanza , A. Carnot , P. Barthelemy , N. Kotecki , M. Maetens , G. Dosin , A.H. Awada , D. Venet , C. Sotiriou , S. Rorive , F. Rothé
{"title":"29P: AURA试验中肌肉侵袭性膀胱癌患者接受新辅助化疗-免疫治疗的全身炎症指数和血小板/淋巴细胞比值的预后价值","authors":"J. Blanc , N. Martinez Chanza , A. Carnot , P. Barthelemy , N. Kotecki , M. Maetens , G. Dosin , A.H. Awada , D. Venet , C. Sotiriou , S. Rorive , F. Rothé","doi":"10.1016/j.iotech.2024.100911","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100911"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"29P Prognostic value of systemic inflammatory index and platelet-to-lymphocyte ratio in muscle-invasive bladder cancer patients treated with neoadjuvant chemo-immunotherapy in the AURA trial\",\"authors\":\"J. Blanc , N. Martinez Chanza , A. Carnot , P. Barthelemy , N. Kotecki , M. Maetens , G. Dosin , A.H. Awada , D. Venet , C. Sotiriou , S. Rorive , F. Rothé\",\"doi\":\"10.1016/j.iotech.2024.100911\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73352,\"journal\":{\"name\":\"Immuno-oncology technology\",\"volume\":\"24 \",\"pages\":\"Article 100911\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-oncology technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590018824002089\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590018824002089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
29P Prognostic value of systemic inflammatory index and platelet-to-lymphocyte ratio in muscle-invasive bladder cancer patients treated with neoadjuvant chemo-immunotherapy in the AURA trial